In a study recently published in the renowned journal “Allergy”, a MedUni Vienna research team shows that COVID-19 leads to considerable long-term changes in the immune system, even in mild cases.
GLP-1 receptor agonists show promise in treating substance use disorders
A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due to study variability and patient